ISMRM 2017

ASL networking at ISMRM 2017

25th Annual Meeting — Honolulu, HI, USA — 22 – 27 April 2017

SUNDAY: ASL Network dinner sponsord by mediri & Gold Standard Phantoms (registration required)



Final report “Arterial Spin Labelling Initiative in Dementia (AID)” – COST AID Action rated and considered 100% successful.



ASL networking at ISMRM 2016

SUNDAY: ASL-Dinner sponsored by mediri (only with invitation/registration)

THURSDAY: Scientific Session on ASL (Room 324-326)


Dear ASL network users,

I wish you a happy and successful year 2016!
As Klaus already announced in the last ASL newsletter we will have some changes for you in 2016! And, most important, we need your help in this. Since our COST Action ran out in Dec 2015, we have to keep up our ASL community by other means. We want to do this by re-activating the homepage and start lively discussions. We would like to have an active forum and maybe a wiki, as well. This is not setup yet, but we are working on it and will come back to you soon. So, stay tuned!

Best wishes,

A report on the last 4 years of COST Action with all activities and achievements listed can be found on the ASL-network page:


Dear all, 

This new and revamped website concerns everyone who is interested in Arterial Spin Labelling (or Labeling ;-)). Whether you are a researcher, an MRI physicist, a radiologist, a clinician, a biologist, hopefully, you will find here a community of people interested in bringing this wonderful method forward. You might like to use it as a simple clinical tool, in any organ of the body; as an interesting method in functional brain activation studies; or to follow the course of diseases in patients or animal models. We have all something to learn from you, and potentially some information to help you.


Welcome to this new website of the ASL Network, of which some of the activities have recently been funded by a European COST Action ( Do not hesitate to contact us if you would like to join, it’s cost- and hassle-free!


Best Regards,


Xavier Golay                                                Matthias Guenther

UCL Institute of Neurology                        Fraunhofer MEVIS/University of Bremen